Your browser doesn't support javascript.
loading
Reply: SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents
Dai, Cong; Dong, Zi-yuan; Wang, Yi-nuo; Huang, Yu-hong; Jiang, Min.
Affiliation
  • Dai, Cong; China Medical University. First Affiliated Hospital. Department of Gastroenterology. Shenyang. China
  • Dong, Zi-yuan; China Medical University. First Affiliated Hospital. Department of Gastroenterology. Shenyang. China
  • Wang, Yi-nuo; China Medical University. First Affiliated Hospital. Department of Gastroenterology. Shenyang. China
  • Huang, Yu-hong; China Medical University. First Affiliated Hospital. Department of Gastroenterology. Shenyang. China
  • Jiang, Min; China Medical University. First Affiliated Hospital. Department of Gastroenterology. Shenyang. China
Rev. esp. enferm. dig ; 115(10): 584-584, 2023.
Article in En | IBECS | ID: ibc-226636
Responsible library: ES1.1
Localization: ES15.1 - BNCS
Subject(s)
Key words
Search on Google
Add to My VHL
Print
XML

Collection: 06-national / ES Database: IBECS Main subject: Inflammatory Bowel Diseases / Mass Vaccination Limits: Humans Language: En Journal: Rev. esp. enferm. dig Year: 2023 Document type: Article
Search on Google
Add to My VHL
Print
XML

Collection: 06-national / ES Database: IBECS Main subject: Inflammatory Bowel Diseases / Mass Vaccination Limits: Humans Language: En Journal: Rev. esp. enferm. dig Year: 2023 Document type: Article